Mosaic ImmunoEngineering, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was USD 0.399043 million compared to USD 0.763484 million a year ago. Basic loss per share from continuing operations was USD 0.06 compared to USD 0.11 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3131 USD | +0.03% | -22.11% | -47.82% |
Apr. 15 | Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 28 | Mosaic ImmunoEngineering, Inc. Receives Letter of Termination from CWRU | CI |
1st Jan change | Capi. | |
---|---|---|
-47.82% | 2.27M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- CPMV Stock
- News Mosaic ImmunoEngineering, Inc.
- Mosaic ImmunoEngineering, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023